Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
As William Miller, CEO of Villya Pharmaceuticals and inventor of our patented technology (WO 2025/064695 A1), I appreciate the discussion around Lillys groundbreaking work in the GLP-1 space
Food and Drug Administration (FDA) has approved Ozempic (semaglutide) as the first and only GLP-1 receptor agonist (GLP-1 RA) specifically indicated to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease (CKD)
Hypoglycemia, which is also called low blood sugar, may cause headache
The long-acting strategies of GLP-1 drugs (amino acid substitutions, fatty acid side chain modifications, Fc fusion proteins, PEGylation) described in the article are only a small part of the current long-acting strategies, which have actually been applied to other protein-peptide drugs as early as
Frequency: Up to 13% of people taking sertraline may feel drowsy
